Sodium Polystyrene Sulfonate Drug Interactions: 1 Major
Sodium Polystyrene Sulfonate Drug Interactions
Check all documented drug-to-drug interactions. Major, moderate, and minor interactions with descriptions.
A therapy excluded from this list does not necessarily mean no interaction exists between that therapy and Sodium Polystyrene Sulfonate. Always confirm against the full prescribing information.
30 interactions
Almasilate
The risk or severity of adverse effects can be increased when Tolevamer is combined with Almasilate.
Level 1 evidence
Aluminium phosphate
The risk or severity of adverse effects can be increased when Tolevamer is combined with Aluminium phosphate.
Level 1 evidence
Aluminum hydroxide
The risk or severity of adverse effects can be increased when Tolevamer is combined with Aluminum hydroxide.
Level 1 evidence
Calcium carbonate
The risk or severity of adverse effects can be increased when Tolevamer is combined with Calcium carbonate.
Level 1 evidence
Digoxin
The risk or severity of Cardiac Arrhythmia can be increased when Tolevamer is combined with Digoxin.
Level 2 evidence
Levothyroxine
Tolevamer can cause a decrease in the absorption of Levothyroxine resulting in a reduced serum concentration and potentially a decrease in efficacy.
Level 1 evidence
Liothyronine
Tolevamer can cause a decrease in the absorption of Liothyronine resulting in a reduced serum concentration and potentially a decrease in efficacy.
Level 1 evidence
Lithium carbonate
The absorption of Lithium carbonate can be decreased when combined with Tolevamer.
Level 2 evidence
Lithium citrate
The absorption of Lithium citrate can be decreased when combined with Tolevamer.
Level 2 evidence
Magaldrate
The risk or severity of adverse effects can be increased when Tolevamer is combined with Magaldrate.
Level 1 evidence
Magnesium carbonate
The risk or severity of adverse effects can be increased when Tolevamer is combined with Magnesium carbonate.
Level 1 evidence
Magnesium hydroxide
The risk or severity of adverse effects can be increased when Tolevamer is combined with Magnesium hydroxide.
Level 1 evidence
Enter your NPI to unlock 1 major interaction for Sodium Polystyrene Sulfonate
Sodium Polystyrene Sulfonate has 30 documented drug interactions. Always review the full list with a pharmacist before co-prescribing.
Sodium Polystyrene Sulfonate has 1 major, 17 moderate, and 12 minor documented interactions.
A therapy excluded from this list does not necessarily mean no interaction exists between that therapy and Sodium Polystyrene Sulfonate. Always confirm against the full prescribing information.